Detalhe da pesquisa
1.
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
Eur J Haematol
; 110(4): 386-395, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36539351
2.
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.
EJHaem
; 5(2): 325-332, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38633125
3.
Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study.
Clin Lymphoma Myeloma Leuk
; 23(5): 370-378, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36804727
4.
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry.
Leuk Lymphoma
; 64(3): 621-627, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38376128